Kinetics of sulforaphane in mice after consumption of sulforaphane-enriched broccoli sprout preparation

Molecular Nutrition and Food Research

Volumn 57, Issue 12, 2013, Pages 2128-2136

  Li, Yanyan ^a,b,c   Zhang, Tao ^b   Li, Xiaoqin ^b   Zou, Peng ^b   Schwartz, Steven J ^c   Sun, Duxin ^b  

^a MONTCLAIR STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Broccoli sprout; Cancer chemoprevention; Kinetics; Mouse; Sulforaphane

Indexed keywords

ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN; SULFORAPHANE;

ANIMAL; ARTICLE; BLOOD; BRASSICA; BROCCOLI SPROUT; CANCER CHEMOPREVENTION; DIET SUPPLEMENTATION; FEMALE; INBRED MOUSE STRAIN; KINETICS; MOUSE; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

BROCCOLI SPROUT; CANCER CHEMOPREVENTION; KINETICS; MOUSE; SULFORAPHANE;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; BRASSICA; FEMALE; FOOD, FORTIFIED; ISOTHIOCYANATES; MICE; MICE, INBRED STRAINS; TISSUE DISTRIBUTION;

EID: 84889011357     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300210     Document Type: Article

References (43)

1. Clarke, J. D., Dashwood, R. H., Ho, E., Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008, 269, 291-304.
2. Zhang, Y., Talalay, P., Cho, C. G., Posner, G. H., A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 1992, 89, 2399-2403.
3. Conaway, C. C., Wang, C. X., Pittman, B., Yang, Y. M. et al., Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 2005, 65, 8548-8557.
4. Fahey, J. W., Zhang, Y., Talalay, P., Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. USA 1997, 94, 10367-10372.
5. Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W. et al., Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7610-7615.
6. Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H. et al., Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA 1994, 91, 3147-3150.
7. Chung, F. L., Conaway, C. C., Rao, C. V., Reddy, B. S., Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000, 21, 2287-2291.
8. Singh, A. V., Xiao, D., Lew, K. L., Dhir, R. et al., Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004, 25, 83-90.
9. Jackson, S. J., Singletary, K. W., Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 2004, 25, 219-227.
10. Juge, N., Mithen, R. F., Traka, M., Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell. Mol. Life Sci. 2007, 64, 1105-1127.
11. Zhang, Y., Tang, L., Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol. Sin. 2007, 28, 1343-1354.
12. Li, Y., Zhang, T., Korkaya, H., Liu, S. et al., Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 2010, 16, 2580-2590.
13. Rodova, M., Fu, J., Watkins, D. N., Srivastava, R. K., Shankar, S., Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. PLoS One 2012, 7, e46083.
14. Li, S. H., Fu, J., Watkins, D. N., Srivastava, R. K. et al., Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol. Cell. Biochem. 2012, 373, 217-227.
15. Kallifatidis, G., Rausch, V., Baumann, B., Apel, A. et al., Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 2009, 58, 949-963.
16. Shapiro, T. A., Fahey, J. W., Dinkova-Kostova, A. T., Holtzclaw, W. D. et al., Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr. Cancer 2006, 55, 53-62.
17. Fahey, J. W., Zalcmann, A. T., Talalay, P., The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001, 56, 5-51.
18. Ratzka, A., Vogel, H., Kliebenstein, D. J., Mitchell-Olds, T. et al., Disarming the mustard oil bomb. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11223-11228.
19. Matusheski, N. V., Swarup, R., Juvik, J. A., Mithen, R. et al., Epithiospecifier protein from broccoli (Brassica oleracea L. ssp. italica) inhibits formation of the anticancer agent sulforaphane. J. Agric. Food Chem. 2006, 54, 2069-2076.
20. Conaway, C. C., Getahun, S. M., Liebes, L. L., Pusateri, D. J. et al., Disposition of glucosinolates and SF in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 2000, 38, 168-178.
21. Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K. et al., Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 1091-1100.
22. Jin, Y., Wang, M., Rosen, R. T., Ho, C. T., Thermal degradation of sulforaphane in aqueous solution. J. Agric. Food Chem. 1999, 47, 3121-3123.
23. Van Eylen, D., Oey, I., Hendrickx, M., Van Loey, A., Kinetics of the stability of broccoli (Brassica oleracea Cv. Italica) myrosinase and isothiocyanates in broccoli juice during pressure/temperature treatments. J. Agric. Food Chem. 2007, 55, 2163-2170.
24. Rosa, E. A. S., Heaney, R. K., Fenwick, G. R., Portas, C. A. M., Glucosinolates in crop plants. Hortic. Rev. 1997, 19, 99-215.
25. Vallejo, F., tomas-Barberan, F. A., Garcia-Viguera, C., Glucosinolates and vitamin C content in edible parts of broccoli florets after domestic cooking. Eur. Food Res. Technol. 2002, 215, 310-316.
26. Matusheski, N. V., Juvik, J. A., Jeffery, E. H., Heating decreases epithiospecifier protein activity and increases SF formation in broccoli. Phytochemistry 2004, 65, 1273-1281.
27. Eylen, D. V., Oey, I., Hendrickx, M., Loey, A. V., Effects of pressure/temperature treatments on stability and activity of endogenous broccoli (Brassica oleracea L. cv. Italica) myrosinase and on cell permeability. J Food Eng. 2008, 89, 178-186.
28. Tian, Q., Rosselot, R. A., Schwartz, S. J., Quantitative determination of intact glucosinolates in broccoli, broccoli sprouts, Brussels sprouts, and cauliflower by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal. Biochem. 2005, 343, 93-99.
29. Agrawal, S., Winnik, B., Buckley, B., Mi, L. et al., Simultaneous determination of sulforaphane and its major metabolites from biological matrices with liquid chromatography-tandem mass spectroscopy. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2006, 840, 99-107.
30. Keum, Y. S., Khor, T. O., Lin, W., Shen, G. et al., Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway. Pharm. Res. 2009, 26, 2324-2331.
31. D'Argenio, D. Z., ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software, Biomedical Simulations Resource, Los Angeles, CA 2009.
32. Lin, W., Dissertation: Molecular and pharmacological study of transcription factor Nrf2: A master regulator of cellular antioxidant defense enzymes. Pharmaceutical Science, Rutgers, The State University of New Jersey, New Brunswick, NJ 2009, pp. 65-78.
33. Wang, P., Ba, Z. F., Burkhardt, J., Chaudry, I. H., Trauma-hemorrhage and resuscitation in the mouse: effects on cardiac output and organ blood flow. Am. J. Physiol. 1993, 264, H1166-H1173.
34. Baxter, L. T., Zhu, H., Mackensen, D. G., Jain, R. K., Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 1994, 54, 1517-1528.
35. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R. et al., Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 1997, 13, 407-484.
36. Vermeulen, M., Klopping-Ketelaars, I. W., van den Berg, R., Vaes, W. H., Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J. Agric. Food Chem. 2008, 56, 10505-10509.
37. Ye, L., Dinkova-Kostova, A. T., Wade, K. L., Zhang, Y. et al., Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta 2002, 316, 43-53.
38. Petri, N., Tannergren, C., Holst, B., Mellon, F. A. et al., Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab. Dispos. 2003, 31, 805-813.
39. Lai, R. H., Miller, M. J., Jeffery, E., Glucoraphanin hydrolysis by microbiota in the rat cecum results in sulforaphane absorption. Food Funct. 2010, 1, 161-166.
40. Nestorov, I., Whole-body physiologically based pharmacokinetic models. Expert Opin. Drug Metabol. Toxicol. 2007, 3, 235-249.
41. Meno-Tetang, G. M., Li, H., Mis, S., Pyszczynski, N. et al., Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1, 3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab. Dispos. 2006, 34, 1480-1487.
42. Lee, J., Son, M. J., Woolard, K., Donin, N. M. et al., Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008, 13, 69-80.
43. Lacy, P. D., Kennedy, J. T., Piccirillo, J. F., Validation of the composite laryngeal recurrence staging system. Cancer 2004, 101, 761-767.